Comparative Efficacy and Safety of Roxithromycin and Clarithromycin in Upper Respiratory Tract Infections E. de Campora, A. Camaioni, M. Leonardi, P. Fardella, and M. Fiaoni
Roxithromycin 300 mg once daily was compared with clarithromycin 250 mg b.i.d, in an open randomized trial in 200 patients with upper respiratory tract infection: sinusitis, pharyngotonsillitis, and otitis media. Average treatment duration
Comparative efficacy and safety of roxithromycin and clarithromycin in upper respiratory tract infections.
Roxithromycin 300 mg once daily was compared with clarithromycin 250 mg b.i.d. in an open randomized trial in 200 patients with upper respiratory trac...